Tissue engineered technologies: regulatory pharmaceuticalization in the European Union.
Human tissues and cells, and tissue engineered (TE) therapies, have been the object of attempts at regulatory regime-building in Europe since the late 1990s. As a sector-in-the-making, or technological zone, TE has been beset by multiple uncertainties. The 2007 Regulation on Advanced Therapy Medicin...
| Publicado en: | Innovation: The European Journal of Social Sciences Vol. 25; no. 4; pp. 389 - 409 |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Taylor & Francis Ltd
Dec2012
|
| Materias: | |
| Acceso en línea: | Ver este registro en EBSCOhost |